Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MIST Milestone Pharmaceuticals Inc.

交易中 04-30 10:04:03 EDT

1.79

-0.03

-1.92%

最高1.87	最低1.78	成交量15.19万
今开1.83	昨收1.82	日振幅4.95%
总市值2.11亿	流通市值1.21亿	总股本1.18亿
成交额27.77万	换手率0.22%	流通股本6,759万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MIST","market":"US","secType":"STK","nameCN":"Milestone Pharmaceuticals Inc.","latestPrice":1.785,"timestamp":1777557815076,"preClose":1.82,"halted":0,"volume":151937,"delay":0,"changeRate":-0.019230769230769308,"floatShares":67594600,"shares":118000000,"eps":-0.751739,"marketStatus":"交易中","change":-0.035,"latestTime":"04-30 10:04:03 EDT","open":1.83,"high":1.8701,"low":1.78,"amount":277741.0639055,"amplitude":0.049505,"askPrice":1.79,"askSize":993,"bidPrice":1.78,"bidSize":5607,"shortable":3,"etf":0,"ttmEps":-0.751739,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777579200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":1.82,"preHourTrading":{"tag":"盘前","latestPrice":1.83,"preClose":1.82,"latestTime":"09:29 EDT","volume":9296,"amount":16769.440184,"timestamp":1777555799069,"change":0.01,"changeRate":0.005495,"amplitude":0.043956},"postHourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.82,"latestTime":"19:50 EDT","volume":13542,"amount":24421.1856,"timestamp":1777506642605,"change":-0.01,"changeRate":-0.005495,"amplitude":0.037637},"volumeRatio":2.100046,"impliedVol":0.9312,"impliedVolPercentile":0.2749},"requestUrl":"/m/hq/s/MIST","defaultTab":"news","newsList":[{"id":"1126939961","title":"里程碑制药启动Reset-Psvt登记研究 旨在为Cardamyst™鼻喷雾剂治疗室上速生成真实世界证据","url":"https://stock-news.laohu8.com/highlight/detail?id=1126939961","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126939961?lang=zh_cn&edition=full","pubTime":"2026-04-10 20:01","pubTimestamp":1775822478,"startTime":"0","endTime":"0","summary":"Milestone Pharmaceuticals Inc.（简称里程碑制药）宣布启动一项名为Reset-Psvt的登记研究项目。该项目旨在收集关于其核心产品Cardamyst™（Etripamil）鼻喷雾剂在阵发性室上性心动过速（PSVT）患者群体中应用的真实世界临床数据。通过系统性登记患者使用情况，该研究将为药物在实际临床环境中的疗效与安全性提供重要佐证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130778055","title":"里程碑制药公布2025年第四季度及全年财报 同步更新Cardamyst™（依曲帕米）鼻喷雾剂治疗PSVT的商业化进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1130778055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130778055?lang=zh_cn&edition=full","pubTime":"2026-03-20 19:13","pubTimestamp":1774005201,"startTime":"0","endTime":"0","summary":"里程碑制药公司今日披露2025财年第四季度及全年财务业绩，并通报其针对阵发性室上性心动过速的创新药物Cardamyst商业化推进的最新动态。公司财报显示，在Cardamyst获批上市的关键财年内，研发投入与商业化准备资金流动呈现战略化布局。公司首席执行官表示：\"Cardamyst的商业化落地是里程碑制药向心血管领域迈出的战略一步，现有资金足以支撑我们加速市场渗透。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618008456","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618008456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618008456?lang=zh_cn&edition=full","pubTime":"2026-03-10 03:39","pubTimestamp":1773085165,"startTime":"0","endTime":"0","summary":"北京时间2026年03月10日03时39分，Milestone Pharmaceuticals Inc.股票出现波动，股价急速拉升5.06%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，An2 Therapeutics, Inc.、Relmada Therapeutics, Inc.、Camp4 Therapeutics Corporation涨幅较大，An2 Therapeutics, Inc.、Acurx Pharmaceuticals, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为207.11%、80.83%、70.55%，振幅较大的相关个股有An2 Therapeutics, Inc.、Camp4 Therapeutics Corporation、Briacell Therapeutics Corp C/Wts ，振幅分别为138.24%、84.76%、66.47%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031003392595464a4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031003392595464a4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146653833","title":"里程碑制药公司宣布将于2026年2月中旬启动Cardamyst全国销售团队部署","url":"https://stock-news.laohu8.com/highlight/detail?id=1146653833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146653833?lang=zh_cn&edition=full","pubTime":"2026-01-26 21:06","pubTimestamp":1769432784,"startTime":"0","endTime":"0","summary":"里程碑制药公司（Milestone Pharmaceuticals Inc.）近日披露，其针对创新药物Cardamyst的全国销售团队部署计划已正式敲定，将于2026年2月中旬全面启动。这一战略举措标志着公司核心产品商业化进程进入关键阶段，为潜在的市场渗透与营收增长奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603809346","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.39%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603809346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603809346?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229138,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时45分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速跳水5.39%。截至发稿，该股报1.93美元/股，成交量89.5765万股，换手率1.05%，振幅5.39%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.00%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224539a4bb19c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224539a4bb19c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121250450","title":"Milestone Pharmaceuticals Inc.宣布欧洲药品管理局受理其鼻喷雾剂Etripamil用于PSVT的上市授权申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1121250450","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121250450?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:03","pubTimestamp":1767704607,"startTime":"0","endTime":"0","summary":"Milestone Pharmaceuticals Inc.宣布，其用于治疗阵发性室上性心动过速（PSVT）的鼻喷雾剂Etripamil的上市授权申请，已获得欧洲药品管理局（EMA）的正式受理。这一关键进展标志着该药物在欧洲监管审批流程中迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120815867","title":"米尔斯通制药股价在盘前交易中上涨34.8%，因FDA批准其心律鼻喷雾剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1120815867","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120815867?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:07","pubTimestamp":1765804032,"startTime":"0","endTime":"0","summary":"米尔斯通制药股价在盘前交易中上涨34.8%，因FDA批准其心律鼻喷雾剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182401118","title":"Milestone获得FDA批准Cardamyst™ (Etripamil)成为首个也是唯一的自我给药鼻喷雾剂，用于治疗成人阵发性室上性心动过速（Psvt）","url":"https://stock-news.laohu8.com/highlight/detail?id=1182401118","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182401118?lang=zh_cn&edition=full","pubTime":"2025-12-13 09:01","pubTimestamp":1765587676,"startTime":"0","endTime":"0","summary":"Milestone获得FDA批准Cardamyst™ (Etripamil)成为首个也是唯一的自我给药鼻喷雾剂，用于治疗成人阵发性室上性心动过速（Psvt）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586265732","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586265732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586265732?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:01","pubTimestamp":1764169316,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日23时01分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报2.60美元/股，成交量74.313万股，换手率0.87%，振幅6.07%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126230156951be166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126230156951be166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585170146","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585170146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585170146?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:44","pubTimestamp":1763747091,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时44分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速拉升5.19%。截至发稿，该股报2.43美元/股，成交量167.259万股，换手率1.96%，振幅7.14%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122014451a4b21cc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122014451a4b21cc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584087137","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.19%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584087137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584087137?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:35","pubTimestamp":1763570130,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日00时35分，Milestone Pharmaceuticals Inc.股票出现波动，股价急速下跌5.19%。截至发稿，该股报2.29美元/股，成交量152.69万股，换手率1.79%，振幅6.87%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.94%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120003530950ed14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120003530950ed14c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582891368","title":"Milestone Pharmaceuticals Inc.盘中异动 大幅上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582891368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582891368?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:34","pubTimestamp":1762785298,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时34分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速拉升5.26%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Cogent Biosciences, Inc.、Inflarx N.V.、Briacell Therapeutics Corp C/Wts 涨幅较大，Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃，换手率分别为76.72%、15.20%、8.69%，振幅较大的相关个股有Cogent Biosciences, Inc.、Inflarx N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为20.18%、17.89%、13.27%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022345894fb948c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022345894fb948c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581009526","title":"Milestone Pharmaceuticals Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581009526?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:34","pubTimestamp":1762446885,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日00时34分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速下挫5.00%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Iovance Biotherapeutics, Inc.、Tectonic Therapeutic, Inc.涨幅较大，Osr Holdings, Inc.、Bio Green Med Solution, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为104.45%、16.03%、15.86%，振幅较大的相关个股有Cytomed Therapeutics Limited、Surrozen Inc C/Wts 01/08/2031 、Genelux Corporation，振幅分别为62.56%、53.54%、40.28%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107003445975890a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107003445975890a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222686","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大涨6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222686?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613467,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速上涨6.47%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1793.97%、381.32%、45.05%，振幅较大的相关个股有Xencor, Inc.、Y-Mabs Therapeutics, Inc.、Savara, Inc.，振幅分别为99.13%、94.67%、6.60%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310798a29c84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310798a29c84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517164681","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164681?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:45","pubTimestamp":1741272315,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时45分，Milestone Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.05%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1299.07%、269.27%、59.20%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为33.60%、30.53%、25.56%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224515963c502c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224515963c502c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517332948","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517332948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517332948?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:45","pubTimestamp":1741185917,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时45分，Milestone Pharmaceuticals Inc.股票出现异动，股价急速上涨6.09%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为485.44%、266.21%、209.56%，振幅较大的相关个股有Silexion Therapeutics Corp、Aditxt, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为26.13%、23.90%、22.67%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224518a260cc73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224518a260cc73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634209","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨6.13%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634209?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012316,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速拉升6.13%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.17%、23.41%、22.45%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为11.70%、9.55%、9.35%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223156a25d3fd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223156a25d3fd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516705723","title":"Milestone Pharmaceuticals Inc.盘中异动 下午盘股价大跌5.17%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516705723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516705723?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:15","pubTimestamp":1740766537,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时15分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速下跌5.17%。截至发稿，该股报1.65美元/股，成交量55.6161万股，换手率1.04%，振幅7.24%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021537a258372d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021537a258372d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514701532","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.03%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514701532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514701532?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:17","pubTimestamp":1740496659,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时17分，Milestone Pharmaceuticals Inc.股票出现异动，股价快速下挫5.03%。截至发稿，该股报1.80美元/股，成交量27.3828万股，换手率0.51%，振幅5.81%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231739abdc89d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231739abdc89d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509708209","title":"Milestone Pharmaceuticals Inc.盘中异动 临近午盘急速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509708209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509708209?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:56","pubTimestamp":1738861001,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时56分，Milestone Pharmaceuticals Inc.股票出现波动，股价快速拉升5.07%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Palatin Technologies, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5946.75%、1569.09%、159.86%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、49.54%。Milestone Pharmaceuticals Inc.公司简介：Milestone Pharmaceuticals Inc是一家生物制药公司，致力于开发和商业化用于治疗心血管适应症的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005641abc4f274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005641abc4f274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.milestonepharma.com","stockEarnings":[{"period":"1week","weight":-0.0945},{"period":"1month","weight":0.802},{"period":"3month","weight":-0.037},{"period":"6month","weight":-0.0521},{"period":"1year","weight":0.4797},{"period":"ytd","weight":-0.099}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.126},{"period":"3month","weight":0.0253},{"period":"6month","weight":0.0433},{"period":"1year","weight":0.2837},{"period":"ytd","weight":0.0435}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Milestone Pharmaceuticals Inc.于2003年7月根据魁北克省法律注册成立。该公司是一家生物制药公司，专注于创新心血管药物的开发和商业化。该公司批准的产品CARDAYSTTM（艾曲帕米）鼻喷雾剂在美国上市，是第一个也是唯一一个经美国食品药品监督管理局批准的自行治疗药物，可供患者随时随地使用。该公司继续直接或通过与合作伙伴的合作，寻求负责美国以外地区的监管机构的营销批准。该公司还在开发用于快速心室率房颤适应症的艾曲帕米，或“AFib-RVR”。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.028702},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.116389},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.185975},{"month":4,"riseRate":0.714286,"avgChangeRate":0.243729},{"month":5,"riseRate":0.666667,"avgChangeRate":0.024602},{"month":6,"riseRate":0.571429,"avgChangeRate":0.044863},{"month":7,"riseRate":0.714286,"avgChangeRate":0.159669},{"month":8,"riseRate":0.571429,"avgChangeRate":0.085263},{"month":9,"riseRate":0.571429,"avgChangeRate":0.012421},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.130693},{"month":11,"riseRate":0.571429,"avgChangeRate":0.153201},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.087166}],"exchange":"NASDAQ","name":"Milestone Pharmaceuticals Inc.","nameEN":"Milestone Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Milestone Pharmaceuticals Inc.,MIST,Milestone Pharmaceuticals Inc.股票,Milestone Pharmaceuticals Inc.股票老虎,Milestone Pharmaceuticals Inc.股票老虎国际,Milestone Pharmaceuticals Inc.行情,Milestone Pharmaceuticals Inc.股票行情,Milestone Pharmaceuticals Inc.股价,Milestone Pharmaceuticals Inc.股市,Milestone Pharmaceuticals Inc.股票价格,Milestone Pharmaceuticals Inc.股票交易,Milestone Pharmaceuticals Inc.股票购买,Milestone Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}